Introduction
In this special 2-part episode, The PVD Channel is pleased to welcome Drs. Michael Lichtenberg and Mike Watts as they share their knowledge and experience with advanced imaging. Replete with evaluation of various imaging modalities, real-world data and a focus on calcification, our expert Faculty will help prepare you to design and enact optimal treatment strategies for your patients with peripheral vascular disease and critical limb ischemia.
Part I – Angiography Alone is Not Enough: Utilizing Advanced Imaging to Define your Strategy with the Right Revascularization Technique
In Part I, join Michael Lichtenberg, MD, FESC for an in-depth exploration of the latest in advanced vascular imaging modalities, technologies and techniques. In his review of challenging cases, real-world data and current clinical studies, Dr. Lichtenberg highlights emerging imaging options that can bolster the use of angiography, helping your patients requiring below-the-knee interventions to achieve improved outcomes.
Part II – Combatting Calcification: From Plaque Modification to Plaque Removal – A Close Look at Atherectomy Choices
In Part II, The PVD Channel welcomes Mike Watts, MD, FSIR for a detailed analysis of the challenges presented by calcification in the treatment of peripheral artery disease and critical limb ischemia. Join Dr. Watts as he takes us into the exam room, demonstrating how calcium removal and/or modification can increase vessel compliance and drug permeability through the vessel wall. Through evaluation of real-world studies and currently available atherectomy devices, learn how familiarity with multiple devices can help you develop treatment algorithms that are tailored to your patients’ individual needs.
Learning Objectives
After completing this activity, the participant should be better able to:
- Explain the advantages and disadvantages of various imaging modalities and their impact on approaches to revascularization
- Describe the challenges presented by calcification in the treatment of PAD and CLI
- Identify the appropriate atherectomy device based on individual patient needs
Target Audience
The educational design of this activity addresses the needs of Interventional Radiologists, Vascular Surgeons, Vascular Specialists, Nurse Practitioners, Radiologic Technologists, and Vascular Allied Health Professionals involved in the treatment of patients with peripheral vascular disease.
Michael Klaus William Lichtenberg, MD, FESC
Chief Medical Officer
Angiology Clinic, Vascular Center
Arnsberg Clinic
Arnsberg, Germany
Dr. Michael Lichtenberg is the Chief Medical Officer and Director of the Angiology Department and Vascular Center at the Arnsberg Clinic in Arnsberg, Germany.
Dr. Lichtenberg earned his medical degree from the Heinrich-Heine Medical University of Dusseldorf, and also studied at the Tulane University School of Medicine in New Orleans, Louisiana and the Texas Heart Institute in Houston, Texas.
An esteemed Interventional Cardiologist and Angiologist with 20 years of experience in endovascular interventions, Dr. Lichtenberg was elected to serve as Managing Director of the German Society for Angiology in 2017. In 2019, he was elected to serve as the society’s President.
Dr. Lichtenberg’s areas of clinical interest include deep venous intervention, peripheral artery disease, coronary thrombosis, and atherosclerosis.
In addition to his day-to-day work in interventional care, his main interest is the evaluation of new devices, techniques and procedures for intervention of peripheral artery disease. Dr. Lichtenberg has performed a series of studies in this area and conducted many clinical trials.
Mike Watts, MD, FSIR
Interventional Radiologist
The Vascular Institute of AMI
Vineland, NJ, USA
Dr. Mike Watts is an interventional radiologist dedicated to providing the highest level of service through clinical excellence and a commitment to patient and family centered care.
Dr. Watts graduated from Colgate University in 2002 with a major in Chemistry. He earned his medical degree at the University of Buffalo in 2006, completed his surgical internship and radiology residency at the Cleveland Clinic in 2011, and a fellowship at the University of Pennsylvania in 2012.
Dr. Watts specializes in advanced peripheral arterial disease techniques, minimally invasive cancer treatments, venous disease, and management of portal hypertension. He has been invited to speak on these topics at multiple regional, national, and international conferences.
Committed to education, he served as the Interventional Radiology Fellowship Director at the University of Pennsylvania and created one of the first Interventional Radiology residencies in the United States. His devotion to hands-on teaching of complex techniques has driven him to continuous improvement through a commitment to lifelong learning and innovation of novel procedural techniques.
Since 2016, he has been committed to limb preservation, treating CLI on a full-time basis using advanced and innovative techniques to bring unsurpassed quality of care to patients throughout Eastern Pennsylvania and New Jersey.
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Educational Awareness Solutions. Global is accredited by the ACCME to provide continuing medical education for physicians.
Physician Credit Designation
Global Education Group designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC Recognition Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 medical knowledge MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Nurse Practitioner Continuing Education
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of Global Education Group and Educational Awareness Solutions. Global Education Group is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 110121. This activity is approved for 1.0 contact hour(s) (which includes 0.0 hour(s) of pharmacology).
American Society of Radiologic Technologists
This activity has been reviewed and approved for 1.0 Category A CE credit by the ASRT.
European Board for Accreditation in Cardiology
This programme is accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) for 1.0 hour(s) of external CE credit(s). Each participant should claim only those hours of credit that have actually been spent in the educational activity.
Term of Offering
This activity was released on January 15, 2022 and is valid for one year. Requests for credit must be made no later than February 1, 2023.
Global Contact Information
For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.
Instructions to Receive Credit
In order to receive credit for this activity, the participant must complete the pre-activity questions, view the program in its entirety, and complete the post-activity questions, evaluation form, and credit request.
Fee Information and Refund/Cancellation Policy
There is no fee for this educational activity.
Disclosure of Conflicts of Interest
Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.
In compliance with EBAC guidelines, all speakers/chairpersons participating in this programme have disclosed or indicated potential conflicts of interest which might cause a bias in the presentations. The Organizing Committee/Course Director is responsible for ensuring that all potential conflicts of interest relevant to the event are declared to the audience prior to the CE activities.
All relevant financial relationships have been mitigated.
The faculty have the following relevant financial relationships with ineligible companies:
|
Name of Faculty or Presenter
|
Reported Financial Relationship
|
|
Michael K. W. Lichtenberg, MD, FESC
|
Consulting Fees: BD Bard, Philips, Boston Scientific, Medtronic
Contracted Research: BD Bard, Philips, Boston Scientific, Medtronic Honoraria: BD Bard, Philips, Boston Scientific, Medtronic Speaker’s Bureau: BD Bard, Philips, Boston Scientific, Medtronic |
|
Mike Watts, MD, FSIR
|
Consulting Fees: Philips Medical, Heraeus Medical
|
The planners and managers have the following relevant financial relationships with ineligible companies:
Contracted Research: Vesper, Humacyte, Boston Scientific, PQ Bypass, Merit Medical, Medtronic, Intervene
Speaker’s Bureau: Philips, Cook Medical, Medtronic, Boston Scientific
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and Educational Awareness Solutions do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
System Requirements
An Internet-connected web browser is required.
This activity is jointly provided by Global Education Group and Educational Awareness Solutions.
This activity is supported by an educational grant from Philips Image Guided Therapy.
